Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
07/02/2008 | CN101210244A Neutrokine-alpha and Neutrokine-alpha splice variants |
07/02/2008 | CN101209337A Medicinal liquor for treating rheumatism and rheumatoid and preparation thereof |
07/02/2008 | CN101209327A Method for preparing medicine for treating sprain and dampen |
07/02/2008 | CN101209326A Dampness eliminating medicinal liquor |
07/02/2008 | CN101209309A Rheumatism treating medicine and preparation thereof |
07/02/2008 | CN101209276A China elder medicinal liqueur for expelling wind dissipating blood stasis and activating collateral flow |
07/02/2008 | CN101209275A Medicament for treating protrusion of lumbar vertebral disc |
07/02/2008 | CN101209259A Use of hyaluronic acid for chondrocyte oxidation resistance and hyperplasia |
07/02/2008 | CN101209171A Pillow containing tea, carbon and Chinese herbal medicine composite granules and preparation method thereof |
07/02/2008 | CN101209111A Edible composition capable of increasing bone density |
07/02/2008 | CN101209100A Ca-enriched flavouring and its manufacturing method |
07/02/2008 | CN101209088A Microorganism polyzyme additive agent for improving pigling growth and development |
07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
07/02/2008 | CN100398519C Tetracyclic benzamide derivatives and methods of use thereof |
07/02/2008 | CN100398145C Medicine composition for treating chronic osteomyelitis and its preparation |
07/02/2008 | CN100398129C Chinese-medicinal preparation for treating femur head aseptic necrosis |
07/02/2008 | CN100398128C Medicine for treating cervical vertebra disease, lumbar intervertebral disk protrusion, bone fracture and crush fracture |
07/02/2008 | CN100398127C Wind dispelling spray and its preparation process |
07/02/2008 | CN100398122C Enteric coated Chinese medicine composition for treating cervical and lumbar spondylopathy |
07/02/2008 | CN100398110C Preparation containing ultra-low-doses of estrogen, patch and reagent box |
07/01/2008 | US7393932 Endothelial cell expression patterns |
07/01/2008 | US7393928 Recombinant gelatins |
07/01/2008 | US7393870 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
07/01/2008 | US7393861 Derivatives of 4-aminopiperidine and their use as a medicament |
07/01/2008 | US7393857 Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases |
07/01/2008 | US7393850 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
07/01/2008 | US7393849 N-[4-Amidinobenzoyl]-N-[3-phenoxybenzyl]-3-(4-biphenyl)-alanyl-glycyl-amide; anticarcinogenic, antidiabetic, anticholesterol agent, cardiovascular disorders, osteoporosis |
07/01/2008 | US7393840 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
07/01/2008 | US7393838 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
07/01/2008 | US7393837 Method for treating metabolic bone disease such as osteomalacia and osteoporosis in a patient by administering a compound that modulates phosphate regulating endopeptidase homolog (PEX) expression and/or PEX enzymatic activity |
06/26/2008 | WO2008076604A1 Bone growth particles and osteoinductive composition thereof |
06/26/2008 | WO2008076417A1 (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease |
06/26/2008 | WO2008075978A2 An extract |
06/26/2008 | WO2008075930A1 Compositions of risedronate and vitamin d3 |
06/26/2008 | WO2008075104A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
06/26/2008 | WO2008075045A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
06/26/2008 | WO2008075038A1 Binding agents to the integrin alpha-11 subunit |
06/26/2008 | WO2008074676A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
06/26/2008 | WO2008074227A1 Synthetic ion channels |
06/26/2008 | WO2008074145A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
06/26/2008 | WO2008074144A1 A composition containing a bisphosphonic acid in combination with vitamin d |
06/26/2008 | WO2008036387A8 Method of treating endothelial dysfunction |
06/26/2008 | US20080153896 Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof |
06/26/2008 | US20080153882 Pharmaceutical Composition Comprising Ppar Regulator |
06/26/2008 | US20080153815 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
06/26/2008 | US20080153785 Pharmaceutical Compositions Containing Biophosphonate for Improving Oral Absorption |
06/26/2008 | US20080153784 Salt of a bisphosphonate anda salt of pentavalent phosphorus oxoacid; osteoporosis |
06/26/2008 | US20080153780 Applying resiniferatoxin in the intracapsular space or in the bursa of joints; wound pain after surgery, arthrosis, rheumatoid arthritis, infectious arthritis, chondrocalcinosis |
06/26/2008 | US20080153751 Albumin Fusion Proteins |
06/26/2008 | US20080153744 Novel cyclosporin alkynes and their utility as pharmaceutical agents |
06/26/2008 | US20080153743 Methods relating to the treatment of fibrosis |
06/26/2008 | US20080153742 Fas peptide mimetics and uses thereof |
06/26/2008 | US20080153107 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
06/26/2008 | US20080152691 Malleable implants containing demineralized bone matrix |
06/26/2008 | US20080152640 administering drugs comprising inhibitor of ATP-binding cassette transporters (ABC-transporter), such as verapamil or valspodar, for the treatment of arthritis; drug screening |
06/26/2008 | CA2709411A1 Binding agents to the integrin alpha-11 subunit, and uses thereof |
06/26/2008 | CA2673337A1 Bone growth particles and osteoinductive composition thereof |
06/26/2008 | CA2672983A1 Modulators of beta-2-adrenergic receptor for treating conditions characterized by disorganized vasculature |
06/26/2008 | CA2672719A1 Pyrazolo [3, 4 -d] pyrimidine p38 map kinase inhibitors |
06/26/2008 | CA2672270A1 Treatments of therapy resistant diseases and drug combinations for treating the same |
06/26/2008 | CA2672191A1 (1r,6s)-2-azabicyclo[4.3.0] nonane-8,8-diphosphonic acid and its use in treating or preventing bone disorders, for example, osteoporosis or paget's disease |
06/26/2008 | CA2671728A1 Pharmaceutical composition comprising a hot-melt granulated lubricant |
06/26/2008 | CA2671727A1 A composition containing a bisphosphonic acid in combination with vitamin d |
06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
06/25/2008 | EP1934262A1 Antibodies to complementary peptides of thrombin or portions thereof |
06/25/2008 | EP1934248A2 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
06/25/2008 | EP1934245A1 Y2 selective receptor agonists for therapeutic interventions |
06/25/2008 | EP1934217A1 New compounds ii |
06/25/2008 | EP1934200A1 Tyrosine kinase inhibitors |
06/25/2008 | EP1933853A1 Tissue disruption treatment and composition for use thereof |
06/25/2008 | EP1861389B1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof |
06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
06/25/2008 | EP1200127B1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
06/25/2008 | CN101208089A 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 Aminothiazole derivatives as human stearoyl desaturase inhibitor -CoA |
06/25/2008 | CN101204570A Plaster for anesthesia and preparation method thereof |
06/25/2008 | CN101204566A Peroral Chinese traditional medicine composite for hyperosteogeny in knee joint |
06/25/2008 | CN101204562A External drug for chronic injury, arthritis, join thydrops and pain in shoulder, neck, waist, and leg |
06/25/2008 | CN101204561A Plaster for rheumatalgia of shoulder, neck, waist, and leg |
06/25/2008 | CN101204545A Medicine for shoulder periarthritis |
06/25/2008 | CN101204533A Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc |
06/25/2008 | CN101204531A Medicament composite for ANFH |
06/25/2008 | CN101204529A Medicine for wound-curing and scar-dispeling |
06/25/2008 | CN101204505A Peroral Chinese traditional medicine composition for osteoporosis |
06/25/2008 | CN101204500A Preparation method and composition and Chinese traditional medicine preparation for preventing and curing hyperuricaemia |
06/25/2008 | CN101204490A Preparation method and uses of fast-acting Chinese traditional medicine |
06/25/2008 | CN101204487A Chinese traditional medicine for fracture |
06/25/2008 | CN101204474A Tincture medicine for wrick |
06/25/2008 | CN101204436A Chinese patent medicine for curing hyperosteogeny in knee joint |
06/25/2008 | CN101204432A Chinese traditional medicine oral liquid preparation for osteoporosis and preparation method thereof |
06/25/2008 | CN101204412A Compound traditional Chinese traditional medicine for osteoporosis |
06/25/2008 | CN101204375A Strontium ranelate dry suspension |
06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
06/25/2008 | CN100396676C Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
06/25/2008 | CN100396667C Unsaturated five heterocycle compound for up-regulating bone formation protein BMP-2 expression activity |
06/25/2008 | CN100396328C Combined medicine for preventing and treating rheumatism, rheumatoid, protrusion of intervertebral disc and hyperosteogeny |
06/25/2008 | CN100396325C Compound medicine prepn. for treating osteoporosis, and its preparation method |